chrisvoncsefalvay/vaers-outcomes huggingface dataset:
injection site pain and tenderness. fatigue , headache, muscle pain , joint pain , chills, fast heartbeat.
Joint stiffness, radiating from shoulder to spine and jaw. Relieved by benadryl. Occured for 3 days before ceasing.
Fevers low grade initially then up to 103.8. Vomiting x 2 days. SOB, dizziness, lethargy/listless, anorexia, inflammation/swelling at site, no diarrhea.
Developed Ringing in left ear and pressure. Now has traveled to right ear. Have NEVER had tinnitus or a significant ear infection. One mild ear infection over 2 decades  ago.  Started with mod pain and throbbing in left ear. Ringing, pain and pressure improved in left ear but still remains. Right ear experienced mild pain. But no ringing or significant pressure. However, this evening, ringing and pressure has now traveled to right ear.
Patient received the vaccine, and 5 minutes later when walking out of the consultation room she fainted and hit her head on the higi machine.
4/18-23 heart palpitations and shortness of breath; 4/19 high BP, 5/17-29: heart palpitations and SOB (severe and constant 5/26-27), lightheaded on 5/23,
69 Y male w PMHx DM2 (insulin dep, last A1c 6.6 8/2021), hypertension, hyperlipidemia, osteoarthritis, severe obesity, benign prostatic hypertrophy, chronic kidney disease (baseline creatinine 1.3-1.7) p/w SOB/cough and found to be COVID positive. Prolonged hospitalization for Hypoxic Respiratory failure from COVID PNA.    COVID Pneumonia, Acute hypoxemic Respiratory failure complicated by Pneumonia - Symptom onset on 8/29/21. COVID positive on 8/30/21. Last fever 102.6 on 9/5. Pt at facility from 9/4 to 9/18/21. He received 10 days of Decadron and Remdesivir daily for 4 days (9/5 - 9/8). It was stopped 1 day early due to new generalized itchy rash. CTA chest obtained on 9/10 and no PE seen. Given his prolonged cough, persistent infiltrates and elevated wbc and yellow sputum 9/14 started Levaquin to treat bacterial superimposed PNA. CXR from 9/12 with retrocardiac opacity. After starting this his cough and sputum production improved and he was weaned off of 2-3L O2 - satting 94% on RA since 9/17. 0-2L at rest and 2L with exertion. Goal O2 sat >92%   Weakness- Likely deconditioning + weak from long course of steroids and being a COVID LONGHAULER. TTE done prior to discharge, which was normal. TSH normal  - HH PT   Mild Hyponatremia due to SIADH - cw free water restriction to 1L and NaCL 1g bid   Maculopapular Rash.  Looked like a drug rash, on the trunk and extremities.  Started rather suddenly on night of 9/8.  Very itchy.  No desquamation or blisters.  Rashes related to remdesivir are uncommon but it is a new medication him and more likely to cause rash than dexamethasone so stopped Remdesivir one day early. - resolved   Acute on chronic kidney disease with proteinuria: suspected volume depletion from dehydration, decr po intake and diarrhea. Baseline is 1.3-1.7. On admission 1.96. Improved with gentle hydration - Cr worse than usual after resuming Jardiance? Will hold and defer to PCP if he should resume   DM2: prior to admission on insulin (NPH 35 U every morning), jardiance, and metformin. Hold metformin. Blood Sugars running high at times.   - Increased NPH to 35u qam, started 5 U NPH in the evening.   - resume home metformin - pt instructed to check bg 3-4 times a day   Hypertension/hyperlipidemia:  Stable. Prior to admission on lisinopril, cardura and atorvastatin.  - Continue doxazosin 8 qhs and Atorvastatin -.Holding Lisinopril    Benign prostatic hypertrophy: Continue pta doxazosin.     Constipation - bowel regimen- colace, senna and miralax.    Lower back pain- hx of LBP. 2/2021MRi normal- likely MSK as it was reproducible - lidoderm patch - p rn tylenol   Subjective:  Says he felt better! Cough continues to improve on antibiotics. Still suctioning out clear and some opaque secretions but feels better. Still SOB and exhausted with exertion, but this is better
Patient received Moderna covid vaccine which is not yet approved for patients under 18.   Pharmacist did not realize only the Pfizer vaccine is approved for under 18 at this time.  Confusion arose from state's phased rollout of vaccine populations, where now all patients 16+ are able to be vaccinated but the limitations on which vaccine were not made abundantly clear.  No adverse events/effects reported.  Patient is in good health with no issues.
The morning after receiving my third dose, I started to experience heart palpitations. I was thinking that it could be related to POTS, but I was not sure. I contacted a cardiologist through a portal, and they told me to rest and take my medicine. I was diagnosed with A-Fib after visiting the doctor. I do not attribute A-Fib to receiving the vaccine because according to my doctor, I had A-Fib prior to receiving my vaccines.
pt recvd vax 16JAN92 & was fussy for next 3 days; seen by MD for extreme irritability adm r/o abd process x-ray neg (rub); d/c next day; f/u noted to have crepitus; CXR for fractured rib -pos;
pt recvd vax & adm in hosp in status epilepticus; on ventilator; t 40;
Developed sore edematous left axilla and left clavicular areas. Clavicle area has notable redness. Taking ibuprofen and ice packs periodically for pain control x 1 day.
Diarrhea next day,  Fever of 101.6 5days,  Large Fever Blister 2 Weeks,  Headache,  No Appetite 8-9 days,  Weak 10 days, loss of balance 10 days  On 6-7 day joint pain in every joint much worse than Covid-19. Right shoulder felt like a long nail shoved down the top of my snhoulder. Back, knees, elbows, ankles hurt worse than Covid-19
Within 3 weeks of first vaccine hands, wrists, and finger joints became inflamed, stiff and swollen. After 2nd dose on 3/3/2021 the symptoms have become much worse and have moved to first my right knee and ankle, then my left knee and the top of both feet, then to the  bottom of both feet, and now in my middle back and both hips. Fingers begin going numb when I use my hands, middle three toes on both feet are tingling like they are going numb, right foot is worse than left.  Edema began in earnest 5/16/2021.
Night of the vaccine: Elevated heart rate, vertigo, muscles locked up in neck, chills, shortness of breath, feeling faint. It induced a panic attack because my husband was gone on a work trip and I was alone with kids some of the symptoms subsided a bit the next day but the vertigo and more elevated heart rate lasted 5 days. After acupuncture on day 3 to try and release muscle tension, and chiropractic treatment, by day 7 I felt almost 100%. I'm a physically active person who works out about 30-40 minutes a day 5 days a week with two young kids at home. This sent me spinning and left me unable to complete normal functions well (driving a car, getting groceries, picking up kids from school) for 5 days.
Sore arm within hour of injection that got worse with rest, facial paralysis within 3 hours, muscle weakness within 12 hours
Very mild tinnitus got noticibly worse.  Now I hear it throughout the day.  It is more difficult to sleep.  I first experienced within a day or so after the first vaccine and it has been that way for 4 months without meaningful improvement.
This spontaneous report as received from a pharmacist via company representative refers to an unspecified number of patients of unknown age and gender. On unknown dated the patients were vaccinated with ZOSTAVAX, vial (route, strength, lot number an expiration date not provided). On unknown dates the patients experienced rash. The patients sought unspecified medical attention. The outcome of rash was unknown. The relatedness between vaccination with ZOSTAVAX and rash was not reported. Additional information has been requested.
This spontaneous report as received from a certified medical assistant, via a company representative, refers to 10 patients of unknown age and genders. No information on their medical history, concurrent conditions or concomitant drugs was provided. On an unknown date, reportedly between 01-MAY-2014 and 01-JUL-2014, the patients were vaccinated with GARDASIL which was improperly stored (doses, administrations sites and routes, lot# and expiration dates were not reported). This is one of several reports from then same reporter. Additional information has been requested.
This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (Mild sore arm), HEADACHE (Mild headache) and NAUSEA (Mild nausea) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination. No Medical History information was reported. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced PAIN IN EXTREMITY (Mild sore arm). 06-Jan-2021, the patient experienced HEADACHE (Mild headache) and NAUSEA (Mild nausea). At the time of the report, PAIN IN EXTREMITY (Mild sore arm), HEADACHE (Mild headache) and NAUSEA (Mild nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.
This report was received from a physician via Pfizer and was assigned manufacturer report number 2015308608, referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 (dose, frequency, route, lot # and expiration date were not reported). No concomitant medications were reported. On an unknown date, the patient experienced a severe local reaction to PNEUMOVAX 23. It was reported that if it would be expected the same type of reaction with a dose of PREVNAR 13 in a patient previously vaccinated with PNEUMOVAX 23. At the time of the report, the outcome of hypersensitivity reaction was unknown. The relatedness between hypersensitivity reaction and PNEUMOVAX 23 was not provided. Additional information has been requested.
Patient stated that she fainted on Memorial day and fell backwards into the bath tub. She needed to be taken to the hospital by ambulance and was in the hospital for a couple weeks. She stated that this immunization caused her to have Bell's Palsy.
Started with wrist and knee pain.  She then had intermittent swelling in her feet,eyes,face also pain in back and axilla.  She had headaches and low grade fever.  All symptoms started 2 weeks after Yellow fever and typhoid vaccine.  She also developed a microvesicular rash on her face and extremities.
I first experienced waves of heat and felt like I was going to pass out. This happened 5-6 times in the first 24 hours. I was dizzy from about 30 min after the shot and still am today. I shivered uncontrollably the first night but have not had chills since. Starting on day 2, I?ve needed to take a deep breath every so often. I also feel the need to cough - just one cough - every so often. Starting day 3, I had a terrible headache that comes and goes. That night my palms, toes, legs, and arms were itchy - no rash seen. My neck was itchy and my throat was scratchy. That ended by morning 4. Starting morning 4, my head feels full - especially my ears. My legs have been on and off tingly. I?m still incredibly dizzy and fatigued.
1 hour after injection; Jittery/rapid hear rate (lasted for a few hours) Day 2: Extreme body/muscle aches Day 1- present.-pain on injection arm, pain on injection site, redness on injection site, continued swelling of injection site, hot to the touch on the injection site.  Day2- present; Fatigue
Patient received both vaccines in (R) arm, that evening she experienced pain. Upon waking she had a quarter size swelling as the day progressed it got larger. At the time she reported swelling (11/25/14) it was getting bigger.
On 3-30-04, child received routine immunization (Pediarix) DTaP, IPV, Hep B, PCV 7 and PV HIB on 4-6-05 mother called PHN and reported that the ever of 4/5 infant ran 101.5 temp. lowered to normal with Tylenol and had screaming for 4-5 hr.
AFTER RECEIVING 2ND SHOT FOR FLU VACCINE, PATIENT STARTED TO PASS OUT. THEN QUICKLY CAME BACK AFTER CONTINUING CALLING OUT PATIENT. SHE DID NOT EAT ANYTHING BEFORE VACCINATIONS AND HAD FAINTED BEFORE. PHARMACY CALLED PARAMEDICS TO FOLLOW UP ON PATIENT BEFORE LEAVING THE PHARMACY. PATIENT WAS GIVEN ORANGE JUICE AND CRACKERS AFTER AWAKENING AND BEFORE PARAMEDICS ARRIVED.
Headache, Myalgia, NauseaVomiting, Fatigue, Insomnia, Chest pain, Righ shoulder Pain.  Narrative:
More than 35 days after the first dose without receiving the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than 35 days after the first dose without receiving the second dose) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 35 days after the first dose without receiving the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than 35 days after the first dose without receiving the second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication were provided.
This spontaneous report was received from a nurse practitioner referring to a 12 month old patient of unknown gender. Concurrent conditions or pertinent medical history were not reported. On 11-AUG-2016, the patient was vaccinated with an extra dose of ROTATEQ (lot # M004890, expiration date: 10-NOV-2017) orally (dose and frequency were unspecified). Concomitant medications were not reported. No adverse effects were reported. Additional information has been requested.
Redness, swelling, fever, fatigue, hot to touch.  Went ER 7/21/10.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy and Seasonal allergy.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No relevant concomitant medications were reported.  Patient stated that after taking Advil (ibuprofen) she felt much better.   This case was linked to MOD-2021-116441 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Follow up attached on 09JUL2021 (TCR form) had treatment medication updated.
SkinRash Narrative:  Rash continues: PCP steroid injections and  antihistamines. Advised not to receive booster if applicable  Other Relevant History:
Patient started to experience pain around injection site the evening after receiving the vaccination. By the next morning it was red around the injection site and firm to the touch. He could not lift his arm even to shoulder level due to the pain.
21FEB96 pt recv vax & exp redness began shortly p/vax;day one p/vax redness increasing on day 3 p/vax;seen in office for reddened-abscess site;tx w/ATB for 5 days;improving;
no adverse effect; patient was administered a dose of GARDASIL followed by a dose of GARDASIL 9; patient was administered a dose of GARDASIL on 09-FEB-2015 followed by a dose of GARDASIL 9 on 01-JAN-2016; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 09-FEB-2015, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) lot # K009482, expiration date: 06-MAR-2017 (dose, site and route of administration were not reported) for prophylaxis. On 01-MAR-2016, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dose, site and route of administration, lot # and expiration date were not reported) for prophylaxis (coded as inappropriate schedule of vaccine administered and interchange of vaccine products). No adverse effect was reported.
This spontaneous report was received from a physician and refers to a patient of unknown age. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 17-APR-2018, the patient was vaccinated with an expired dose of RECOMBIVAX HB injection, intramuscularly, lot # L040458 with expiration date on 04-FEB-2018. No adverse effects were reported.
This spontaneous report as received from a certified medical assistant refers two unspecified patients of unknown ages and genders who on an unknown dates were vaccinated with an improperly stored (incorrect product storage) doses of GARDASIL (lot # K009482, expiration date 16-MAR-2017) (dose and route were not reported). No adverse effect reported. It was unknown if the patients sought medical attention. This is one of several reports from the same source. Additional information has been requested.
nerve damage to the forehead; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of nerve damage in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced nerve damage (Verbatim: nerve damage to the forehead). The outcome of the nerve damage was not reported.   It was not reported if the reporter considered the nerve damage to be related to Shingles vaccine.     It was not reported if the company considered the nerve damage to be related to Shingles vaccine.   Additional Information: GSK receipt date: 01-Mar-2023 This case was reported by a patient via interactive digital media. The patient had nerve damage to the forehead; it feels like water dripping down forehead. The patient received shingles shot too. The follow up would not possible, as no contact, details were available.
This spontaneous report as received from a licensed vocational nurse (L.V.N) refers to some patients of unknown age. On an unknown date the patients were vaccinated with Hepatitis A vaccine (manufacturer unknown) dose 1 (dose, route, lot# and expiration date unknown). On an unknown date the patients received their booster dose of hepatitis A vaccine, (manufacturer unknown) too early. No adverse effect reported. This is one of several reports from the same reporter. Additional information has been requested.
Patient received first dose of Pfizer vaccine 3/24/21. Patient became unsteady and was directed to stretcher. Patient has a hx of HTN and reports not taking his BP medication for "a while." Patient was unsure what BP medication he was on. Reports potentially taking Lasix and Vit K. Patient reports not eating or drinking prior to receiving the vaccination. Alert and oriented. Denies SOB/chest pain.     Vitals taken at 10:45AM:  BP 197/11  HR 75 SPO2 98% RA   ED rapid response called. Pt unable to stand up from stretcher.   Patient was taken to ED and neurology was consulted.  Neurology noted:  55-year-old man past medical history of hypertension coming with uncontrolled hypertension systolic over 220.  Concern for gait instability, no evidence of strength weakness on any extremity with confrontational testing.  No evidence of change in altered mental status, no evidence of cranial nerve palsy, and no evidence of sensory loss.   No evidence of coordination problems with finger-to-nose testing and heel-to-shin testing bilaterally.  He exhibits 5 out of 5 confrontational testing to all extremities muscles as above albeit with giveaway weakness.  NIHSS 0.     Although patient presents within TPA window he has had no disabling symptoms and therefore is not a candidate for TPA.  Although the patient presents with a mechanical thrombectomy window he has no disabling symptoms and no evidence of LVO either on exam or my preliminary read of his CTA head and neck.  As such he is not a candidate for mechanical thrombectomy.   Symptoms do not localize well although patient presents with clear hypertensive urgency versus hypertensive emergency.  Would recommend full medical work-up for this condition as we rule out signs of acute ischemic stroke.   Patient passes dysphagia screen in the ED.  Recommendation: 1. Admit to Observation.  2. MRI brain without contrast 3. Obtain stroke labs A1c, TSH, lipid profile 4. PT OT consult evaluation and treat 5. Social worker and case management consult for stroke work-up
pt was in hospital from 2/3 - 2/5/22 with UTI and a positive COVID result; initially thought to be a reinfection of COVID (pt had a previous positive COVID test on 1/5/22) and was started on Decadron; after further review with ID, the positive result on 2/3/22 was due to the previous infection; physicians believe the acute on chronic hypoxia is related to aspiration pneumonia, the Decadron was dc'd; pt was treated with ABX; on O2 supplementation; dc'd to hospice where pt died 4 days later
HEADACHE; This spontaneous report received from a patient via a company representative concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache. This report was non-serious.
pt admitted to hosp with c/o increasing SOB, fatigue, productive cough; positive for COVID; started on ABX; COVID pneumonia; O2 supplementation; pt's condition worsened; respiratory alkalosis; required intubation; pt suffered a PEA cardiac arrest and did not survive; she passed away in the hospital
vaccine given 9/10/08. Both legs became sore and stiffon 9/11/08. I contacted nurse today her statement was symptoms not un-natural, give tylenol, could last several days.